Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV004018181 | SCV004848694 | likely pathogenic | Classic homocystinuria | 2023-02-02 | criteria provided, single submitter | clinical testing | The p.Ile278Ser variant in CBS has been reported in one individual with classic homocystinuria in compound heterozygosity with a pathogenic variant. (Cozar 2011 PMID 21520339). The variant was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Another variant involving this codon (p.Ile278Thr) has been identified in individuals with homocystinuria and is classified as pathogenic by this laboratory. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive classic homocystinuria. ACMG/AMP criteria applied: PM3, PM5, PP3, PM2_Supporting. (This variant did not meet the variant calling quality criteria, and was included because it has been previously reported as a clinically significant variant.) |